PGP and malignant colon neoplasm: There was also a study reporting that cryptotanshinone and dihydrotanshinone reversed doxorubicin and irinotecan resistance in SW620 cells of colon cancer by decreasing the level of P-gp mRNA and blocking P-gp ATPase activity (Hu et al., 2014).